Ingredion (INGR) Cash & Equivalents (2009 - 2026)

Ingredion (INGR) has 18 years of Cash & Equivalents data on file, last reported at $914.0 million in Q1 2026.

• Quarterly Cash & Equivalents rose 9.2% year-over-year to $914.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $914.0 million (up 9.2% YoY) and the FY2025 annual result came in at $1.0 billion, up 3.31% from the prior year.
• Cash & Equivalents fell to $914.0 million in Q1 2026, from $1.0 billion in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $1.0 billion in Q4 2025 to a low of $236.0 million in Q4 2022.
• A 5-year average of $596.2 million and a median of $471.5 million in 2024 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2022 — Cash & Equivalents plunged 43.75% — and 2024, when it soared 161.79%.
• Tracing INGR's Cash & Equivalents over 5 years: stood at $236.0 million in 2022, then soared by 69.92% to $401.0 million in 2023, then surged by 148.63% to $997.0 million in 2024, then grew by 3.31% to $1.0 billion in 2025, then slipped by 11.26% to $914.0 million in 2026.
• The last three Cash & Equivalents figures came in at $914.0 million (Q1 2026), $1.0 billion (Q4 2025), and $915.0 million (Q3 2025), per Business Quant data.